IconICLR
ICLR
About: Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
Employees: 41,250
0
Funds holding %
of 7,312 funds
0
Analysts bullish %
of 7 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
0.44% less ownership
Funds ownership: 92.07% [Q4 2024] → 91.63% (-0.44%) [Q1 2025]
7% less funds holding
Funds holding: 585 [Q4 2024] → 545 (-40) [Q1 2025]
15% less repeat investments, than reductions
Existing positions increased: 186 | Existing positions reduced: 219
18% less capital invested
Capital invested by funds: $15.9B [Q4 2024] → $13.1B (-$2.85B) [Q1 2025]
25% less funds holding in top 10
Funds holding in top 10: 16 [Q4 2024] → 12 (-4) [Q1 2025]
25% less first-time investments, than exits
New positions opened: 71 | Existing positions closed: 95
39% less call options, than puts
Call options by funds: $14.9M | Put options by funds: $24.6M
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$150
0%
upside
Avg. target
$161
7%
upside
High target
$173
15%
upside
7 analyst ratings
2 positive
29%
5 neutral
71%
0 negative
0%
Evercore ISI Group Ross Muken | 13%upside $170 | Outperform Maintained | 9 Jul 2025 |
Mizuho Ann Hynes | 15%upside $173 | Outperform Maintained | 15 May 2025 |
Barclays Luke Sergott | 3%upside $155 | Equal-Weight Maintained | 2 May 2025 |
Goldman Sachs Matthew Sykes | 6%upside $160 | Neutral Maintained | 2 May 2025 |
Baird Eric Coldwell | 6%upside $160 | Neutral Maintained | 2 May 2025 |
Financial journalist opinion
Based on 4 articles about ICLR published over the past 30 days
Negative
The Motley Fool
3 days ago
LVM Capital Management Dumps 16,000 ICON Public Shares Worth $2.6 million
According to an SEC filing dated July 2, 2025, LVM Capital Management reduced its position in ICON Public Limited (ICLR 0.92%) by selling 16,096 shares. The transaction was valued at $2.58 million.
Neutral
Business Wire
4 days ago
ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the company's leadership position in the clinical research industry, cutting-edge innovation, its efforts in inclusion and sustainability, and as an employer of choice. Acknowledging ICON's leadership in the application of innovative AI technologies in the industry, the organisation.
Positive
Seeking Alpha
2 weeks ago
ICON: With A 57% Drop, Trump Legislation, And Debt Reduction, Is The Stock Undervalued?
The DCF model suggests that ICON is undervalued by 98.23%. Between 2018 and 2024, the company's revenues increased by 219.04% and by 145.30%, respectively. This year, ICLR will implement a program to repurchase $750 million of its outstanding common shares.
Neutral
Business Wire
2 weeks ago
ICON plc Schedules Second Quarter 2025 Earnings Conference Call
DUBLIN--(BUSINESS WIRE)--ICON plc Schedules Second Quarter 2025 Earnings Conference Call.
Neutral
Business Wire
1 month ago
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm.
Positive
Zacks Investment Research
1 month ago
Here's Why You Should Retain ICLR Stock in Your Portfolio Now
Investors remain optimistic about ICON, driven by its commitment to enhance clinical delivery by integrating AI and impressive strategic pacts.
Neutral
PRNewsWire
1 month ago
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES , June 2, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before June 2, 2025.
Neutral
PRNewsWire
1 month ago
ICLR Shareholders Have the Right to Lead the ICON Public Limited Company Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ICLR
LOS ANGELES , June 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR) for violations of the federal securities laws. Shareholders who purchased the Company's securities between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before June 2, 2025.
Neutral
PRNewsWire
1 month ago
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES , May 28, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before June 2, 2025.
Neutral
Business Wire
1 month ago
ICON plc to Present at the William Blair 45th Annual Growth Stock Conference
DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the William Blair 45th Annual Growth Stock Conference.
Charts implemented using Lightweight Charts™